Ambulatory continuous infusion ifosfamide with oral etoposide in advanced sarcomas
- 15 November 1993
- Vol. 72 (10) , 2963-2969
- https://doi.org/10.1002/1097-0142(19931115)72:10<2963::aid-cncr2820721017>3.0.co;2-w
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Phase III Comparison of Doxorubicin and Dacarbazine Given by Bolus Versus Infusion in Patients With Soft-Tissue Sarcomas: A Southwest Oncology Group StudyJNCI Journal of the National Cancer Institute, 1991
- Dosing and side-effects of ifosfamide plus mesnaZeitschrift für Krebsforschung und Klinische Onkologie, 1991
- Very Low Doses of Warfarin Can Prevent Thrombosis in Central Venous CathetersAnnals of Internal Medicine, 1990
- Combination Chemotherapy With Doxorubicin, Dacarbazine, and Ifosfamide in Advanced Adult Soft Tissue SarcomaJNCI Journal of the National Cancer Institute, 1989
- Phase II Study of Ifosfamide-Etoposide-Mesna in Adults With Advanced Nonosseous SarcomasJNCI Journal of the National Cancer Institute, 1989
- Cyclophosphamide versus ifosfamide: Final report of a randomized phase II trial in adult soft tissue sarcomasEuropean Journal of Cancer and Clinical Oncology, 1987
- Etoposide (VP-16–213)New England Journal of Medicine, 1985
- Ifosfamide-pharmacology, safety and therapeutic potentialCancer Treatment Reviews, 1985
- High-dose ifosfamide and mesna as continuous infusion over five days—a phase I/II trialCancer Treatment Reviews, 1983
- Reduction of Doxorubicin Cardiotoxicity by Prolonged Continuous Intravenous InfusionAnnals of Internal Medicine, 1982